Phil Hass

1.3k total citations
11 papers, 1.0k citations indexed

About

Phil Hass is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology and Molecular Biology. According to data from OpenAlex, Phil Hass has authored 11 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Radiology, Nuclear Medicine and Imaging, 5 papers in Immunology and 4 papers in Molecular Biology. Recurrent topics in Phil Hass's work include Monoclonal and Polyclonal Antibodies Research (5 papers), Glycosylation and Glycoproteins Research (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Phil Hass is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (5 papers), Glycosylation and Glycoproteins Research (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Phil Hass collaborates with scholars based in United States, France and Australia. Phil Hass's co-authors include Joe Kowalski, Austin Gurney, Franklin Peale, Linda Rangell, Gretchen Frantz, Napoleone Ferrara, Jennifer LeCouter, Kenneth J. Hillan, Zemin Zhang and Leo Deguzman and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Journal of Molecular Biology.

In The Last Decade

Phil Hass

11 papers receiving 992 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Phil Hass United States 9 424 214 197 179 134 11 1.0k
Karl X. Chai United States 24 796 1.9× 278 1.3× 253 1.3× 110 0.6× 64 0.5× 48 1.6k
Linda S. Gutierrez United States 17 476 1.1× 250 1.2× 394 2.0× 47 0.3× 157 1.2× 26 1.2k
Fusanori Yotsumoto Japan 26 750 1.8× 268 1.3× 373 1.9× 23 0.1× 211 1.6× 75 1.6k
Toshimasa Nakagawa Japan 16 486 1.1× 86 0.4× 424 2.2× 76 0.4× 16 0.1× 29 1.2k
Tetsuya Gatanaga United States 18 605 1.4× 236 1.1× 930 4.7× 46 0.3× 64 0.5× 37 1.7k
Roberto Salvi Switzerland 20 441 1.0× 73 0.3× 238 1.2× 12 0.1× 197 1.5× 36 1.2k
Mary Kearns‐Jonker United States 20 658 1.6× 54 0.3× 417 2.1× 40 0.2× 65 0.5× 66 1.5k
Stefan Ries Germany 23 801 1.9× 127 0.6× 158 0.8× 118 0.7× 6 0.0× 36 1.5k
Max L. Tejada United States 12 922 2.2× 159 0.7× 349 1.8× 20 0.1× 153 1.1× 19 1.4k
Elizabeth R. Bergert United States 26 754 1.8× 133 0.6× 121 0.6× 16 0.1× 272 2.0× 43 1.9k

Countries citing papers authored by Phil Hass

Since Specialization
Citations

This map shows the geographic impact of Phil Hass's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phil Hass with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phil Hass more than expected).

Fields of papers citing papers by Phil Hass

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Phil Hass. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phil Hass. The network helps show where Phil Hass may publish in the future.

Co-authorship network of co-authors of Phil Hass

This figure shows the co-authorship network connecting the top 25 collaborators of Phil Hass. A scholar is included among the top collaborators of Phil Hass based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Phil Hass. Phil Hass is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Chen, Yvonne, Maciej Paluch, Julie A. Zorn, et al.. (2020). Targeted IgMs agonize ocular targets with extended vitreal exposure. mAbs. 12(1). 1818436–1818436. 3 indexed citations
2.
Gadkar, Kapil, Cinthia V. Pastuskovas, J. Michael Elliott, et al.. (2015). Design and Pharmacokinetic Characterization of Novel Antibody Formats for Ocular Therapeutics. Investigative Ophthalmology & Visual Science. 56(9). 5390–5390. 55 indexed citations
3.
Pantua, Homer, Jingyu Diao, Mark Ultsch, et al.. (2013). Glycan Shifting on Hepatitis C Virus (HCV) E2 Glycoprotein Is a Mechanism for Escape from Broadly Neutralizing Antibodies. Journal of Molecular Biology. 425(11). 1899–1914. 97 indexed citations
4.
Wilson, Nicholas S., Becky Yang, Adriana Baz Morelli, et al.. (2011). ISCOMATRIX vaccines mediate CD8+ T‐cell cross‐priming by a MyD88‐dependent signaling pathway. Immunology and Cell Biology. 90(5). 540–552. 85 indexed citations
5.
Wilson, Nicholas S., Becky Yang, Adriana Baz Morelli, et al.. (2011). Supplementary Figure 2. 45 indexed citations
6.
DeForge, Laura, Kelly M. Loyet, Donnie Delarosa, et al.. (2010). Evaluation of heterophilic antibody blocking agents in reducing false positive interference in immunoassays for IL-17AA, IL-17FF, and IL-17AF. Journal of Immunological Methods. 362(1-2). 70–81. 26 indexed citations
7.
Camenisch, Gieri, M. Teresa Pisabarro, Daniel Sherman, et al.. (2002). ANGPTL3 Stimulates Endothelial Cell Adhesion and Migration via Integrin αvβ3 and Induces Blood Vessel Formation in Vivo. Journal of Biological Chemistry. 277(19). 17281–17290. 205 indexed citations
8.
LeCouter, Jennifer, Joe Kowalski, Jessica Foster, et al.. (2002). Identification of an Angiogenic Mitogen Selective for Endocrine Gland Endothelium. Obstetrical & Gynecological Survey. 57(1). 32–34. 9 indexed citations
9.
LeCouter, Jennifer, Joe Kowalski, Jessica Foster, et al.. (2001). Identification of an angiogenic mitogen selective for endocrine gland endothelium. Nature. 412(6850). 877–884. 456 indexed citations
10.
Ward, L. R., John Threlfall, HJ Smith, et al.. (2000). Salmonella enteritidis epidemic [2] (multiple letters). 287(5459). 1753–1754. 6 indexed citations
11.
Wong, W L, et al.. (1990). A monoclonal-antibody-based enzyme-linked immunosorbent assay of lipoprotein(a). Clinical Chemistry. 36(2). 192–197. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026